Kenneth Reed
Fortuna: 4 M $ al 31/05/2026
Fortuna: 4 M $ al 31/05/2026
Kenneth Reed is the founder of Prescient Pharma LLC.
Current jobs include Director at Minerva Biotechnologies Corp.
and Independent Director at RedHill Biopharma Ltd. Education history includes an undergraduate degree from Brown University, a doctorate from the University of Medicine & Dentistry of New Jersey, and an undergraduate degree from Harvard Medical School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
REDHILL BIOPHARMA LTD. 0,08 % | 27/04/2026 | 42.130.000 ( 0,08 % ) | 4 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| REDHILL BIOPHARMA LTD. | Director/Miembro de la Junta | 15/12/2009 |
Minerva Biotechnologies Corp.
Minerva Biotechnologies Corp. Medical DistributorsDistribution Services Provides medical services | Director/Miembro de la Junta | 21/02/2011 |
| Empresas | Cargo | Fin |
|---|---|---|
Prescient Pharma LLC | Fundador | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Minerva Biotechnologies Corp.
Minerva Biotechnologies Corp. Medical DistributorsDistribution Services Provides medical services | Distribution Services |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Medicine & Dentistry of New Jersey
University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RedHill Biopharma Ltd.
RedHill Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides GI, infectious diseases, medical countermeasures and oncology services | Health Technology |
Prescient Pharma LLC |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.